NCT00643071View on ClinicalTrials.gov

Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Ulcerative Colitis
Interventions
DRUG

Tacrolimus

Oral

Trial Locations (6)

Unknown

Chūbu

Hokkaido

Kansai

Kanto

Kyusyu

Shin'etsu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00643071 - Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients | Biotech Hunter | Biotech Hunter